Physician profile
Robert Smith
NPI 1023335007
$7,105.72
in general payments reported to CMS, 2019-2025
12 companies · $960 in 2025
The $960 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $193 · 2021: $376 · 2022: $1,122 · 2023: $1,224 · 2024: $2,544 · 2025: $960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,294 · Travel and Lodging: $1,434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,293.61 |
| Travel and Lodging | $1,434.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $4,293.77 | 2019-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $1,132.72 | 2021-2025 | Endurant Iis, Corevalve Evolut R |
| Silk Road Medical, INC. | $682.30 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Edwards Lifesciences Corporation | $354.74 | 2025 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $343.81 | 2019 | |
| Phathom Pharmaceuticals, INC. | $101.60 | 2024 | Voquezna |
| Lemaitre Vascular, INC. | $74.80 | 2024 | Artegraft Vascular Graft |
| Bolton Medical INC | $29.65 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Solventum Corporation | $27.83 | 2025 | Prevena, V.A.C.Ulta |
| Neuros Medical, INC. | $25.08 | 2025 | Altius |
| Inari Medical, INC. | $24.78 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Terumo Medical Corporation | $14.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.